This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Exxonmobil Research and Engineering Company. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Vincent A. Bielinski: Innovator in Biological Containment
Introduction
Vincent A. Bielinski is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the regulation of toxin and antitoxin genes in genetically engineered microorganisms. His work aims to enhance biological containment and prevent the uncontrolled spread of engineered strains.
Latest Patents
Vincent holds a patent titled "Regulation of toxin and antitoxin genes for biological containment." This invention focuses on the regulation of toxin and/or antitoxin genes in genetically engineered microorganisms, such as cyanobacterial or eukaryotic algal strains. The patent addresses methods for controlling the growth and survival of these engineered microorganisms, ensuring safety and containment.
Career Highlights
Vincent A. Bielinski is associated with ExxonMobil Research and Engineering Company, where he applies his expertise in biotechnology. His innovative work has positioned him as a key figure in the development of safe and effective biotechnological solutions.
Collaborations
Vincent collaborates with talented individuals such as Nicholas Bauman and Kate Lyons Boyd. Their combined efforts contribute to advancing research and innovation in the field of biotechnology.
Conclusion
Vincent A. Bielinski's contributions to biological containment through his innovative patent reflect his commitment to safety in biotechnology. His work continues to influence the industry and pave the way for future advancements.